JP2022554330A5 - - Google Patents
Info
- Publication number
- JP2022554330A5 JP2022554330A5 JP2022525588A JP2022525588A JP2022554330A5 JP 2022554330 A5 JP2022554330 A5 JP 2022554330A5 JP 2022525588 A JP2022525588 A JP 2022525588A JP 2022525588 A JP2022525588 A JP 2022525588A JP 2022554330 A5 JP2022554330 A5 JP 2022554330A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- compound according
- alkylene
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/113957 | 2019-10-29 | ||
| CN2019113957 | 2019-10-29 | ||
| CN2020087022 | 2020-04-26 | ||
| CNPCT/CN2020/087022 | 2020-04-26 | ||
| PCT/CN2020/124381 WO2021083209A1 (en) | 2019-10-29 | 2020-10-28 | Ssao inhibitors and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022554330A JP2022554330A (ja) | 2022-12-28 |
| JP2022554330A5 true JP2022554330A5 (enExample) | 2023-11-06 |
| JP7703272B2 JP7703272B2 (ja) | 2025-07-07 |
Family
ID=75714874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525588A Active JP7703272B2 (ja) | 2019-10-29 | 2020-10-28 | Ｓｓａｏ阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11472769B2 (enExample) |
| EP (1) | EP4051669A4 (enExample) |
| JP (1) | JP7703272B2 (enExample) |
| KR (1) | KR20220090553A (enExample) |
| CN (1) | CN114901649B (enExample) |
| AU (1) | AU2020377093B2 (enExample) |
| BR (1) | BR112022007974A2 (enExample) |
| CA (1) | CA3155114A1 (enExample) |
| IL (1) | IL292416B2 (enExample) |
| MX (1) | MX2022005199A (enExample) |
| WO (1) | WO2021083209A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020377093B2 (en) | 2019-10-29 | 2026-02-26 | Eccogene Inc. | SSAO inhibitors and use thereof |
| CN117624080A (zh) * | 2023-11-30 | 2024-03-01 | 绍兴上虞新银邦生化有限公司 | 一种丙硫菌唑中间体的合成方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070293548A1 (en) * | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
| CN101917845A (zh) * | 2007-11-21 | 2010-12-15 | 法马克西斯制药公司 | Ssao/vap-1的卤代烯丙胺抑制剂及其用途 |
| LT3002278T (lt) | 2011-03-15 | 2017-06-26 | Astellas Pharma Inc. | Guanidino junginys |
| AU2013255103B2 (en) | 2012-05-02 | 2016-09-29 | Syntara Limited | Substituted 3-haloallylamine inhibitors of SSAO and uses thereof |
| AU2016301745B2 (en) | 2015-08-06 | 2020-07-16 | Ube Industries, Ltd. | Substituted guanidine derivative |
| US10730850B2 (en) | 2016-03-03 | 2020-08-04 | Boehringer Ingelheim International Gmbh | Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors |
| WO2017148518A1 (en) | 2016-03-03 | 2017-09-08 | Boehringer Ingelheim International Gmbh | 4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors |
| EP3455216B1 (en) | 2016-05-12 | 2020-11-04 | Boehringer Ingelheim International GmbH | Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors |
| WO2018027892A1 (en) | 2016-08-12 | 2018-02-15 | Eli Lilly And Company | Amino pyrimidine ssao inhibitors |
| US20210212968A1 (en) | 2016-10-19 | 2021-07-15 | Boehringer Ingelheim International Gmbh | Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof |
| WO2018148856A1 (en) | 2017-02-14 | 2018-08-23 | Eli Lilly And Company | Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors |
| US20200087248A1 (en) | 2017-04-28 | 2020-03-19 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Fluoroallylamine Derivative And Use Thereof |
| AU2018287777B2 (en) | 2017-06-20 | 2020-05-21 | Shandong Danhong Pharmaceutical Co., Ltd. | SSAO inhibitor |
| CN109251166B (zh) | 2017-07-13 | 2021-11-05 | 广东东阳光药业有限公司 | 抑制ssao/vap-1的胺类化合物及其在医药上的应用 |
| WO2019024924A1 (zh) * | 2017-08-04 | 2019-02-07 | 广东东阳光药业有限公司 | 抑制ssao/vap-1的胺类化合物及其在医药上的应用 |
| CN109810041B (zh) | 2017-11-21 | 2023-08-15 | 药捷安康(南京)科技股份有限公司 | 卤代烯丙基胺类ssao/vap-1抑制剂及其应用 |
| CN108047213A (zh) | 2017-12-22 | 2018-05-18 | 佛山汉方中医医院有限公司 | 一种含硫环的氟噻吩的二环腈类化合物及其用途 |
| CN108003166A (zh) | 2017-12-23 | 2018-05-08 | 广东赛博科技有限公司 | 含哌嗪基和哌嗪三唑类结构化合物、制备方法及其用途 |
| CN107935993A (zh) | 2017-12-29 | 2018-04-20 | 佛山汉方中医医院有限公司 | 甲基金刚烷和硝基吡啶结构衍生物、其制备方法及其用途 |
| WO2019241751A1 (en) * | 2018-06-15 | 2019-12-19 | Metacrine, Inc. | Ssao inhibitors and uses thereof |
| EP3870162A4 (en) * | 2018-10-24 | 2022-08-24 | Metacrine, Inc. | SSAO INHIBITORS AND USES THEREOF |
| AU2020377093B2 (en) | 2019-10-29 | 2026-02-26 | Eccogene Inc. | SSAO inhibitors and use thereof |
-
2020
- 2020-10-28 AU AU2020377093A patent/AU2020377093B2/en active Active
- 2020-10-28 EP EP20883108.1A patent/EP4051669A4/en active Pending
- 2020-10-28 IL IL292416A patent/IL292416B2/en unknown
- 2020-10-28 MX MX2022005199A patent/MX2022005199A/es unknown
- 2020-10-28 WO PCT/CN2020/124381 patent/WO2021083209A1/en not_active Ceased
- 2020-10-28 BR BR112022007974A patent/BR112022007974A2/pt unknown
- 2020-10-28 US US17/082,323 patent/US11472769B2/en active Active
- 2020-10-28 CN CN202080090778.XA patent/CN114901649B/zh active Active
- 2020-10-28 KR KR1020227017566A patent/KR20220090553A/ko active Pending
- 2020-10-28 CA CA3155114A patent/CA3155114A1/en active Pending
- 2020-10-28 JP JP2022525588A patent/JP7703272B2/ja active Active
-
2022
- 2022-05-05 US US17/737,580 patent/US11964942B2/en active Active
-
2025
- 2025-01-16 US US19/024,064 patent/US20250326721A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP6964096B2 (ja) | ３−オキソ−２，６−ジフェニル−２，３−ジヒドロピリダジン−４−カルボキサミド類 | |
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| JP7611278B2 (ja) | 金属酵素阻害剤化合物 | |
| JP2024543983A5 (enExample) | ||
| JP2022522486A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| JP2023544476A5 (enExample) | ||
| JP2022501429A5 (enExample) | ||
| JP2010540508A5 (enExample) | ||
| JP2021527125A5 (enExample) | ||
| MXPA02009621A (es) | Derivados de oxazol y sus usos como inhibidores de tirosina cinasa. | |
| JP2022519131A5 (enExample) | ||
| JP2005506308A5 (enExample) | ||
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| JP2024520630A5 (enExample) | ||
| JP2023516235A5 (enExample) | ||
| JP2022554330A5 (enExample) | ||
| JP2024507414A5 (enExample) | ||
| JP2023518474A5 (enExample) | ||
| JP2004525183A5 (enExample) | ||
| JP2024517769A5 (enExample) | ||
| JP2021530488A5 (enExample) | ||
| CN109803657B (zh) | 药物组合物 | |
| JP2024515061A5 (enExample) |